白介素35(IL35)多克隆抗體 

• 來源多抗制備
• 宿主兔
• 效價-
• Ig類型IgG
• 純化方式抗原特異性親和純化
• 白介素35(IL35)多克隆抗體標記物無標記物
• 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
• 性狀液體
• 濃度200ug/ml
• 且適物種-
• 應用WB; ICC; IHC-P; IHC-F; ELISA; IP; IF; FCM.
• 白介素35(IL35)多克隆抗體Polyclonal Antibody to Interleukin 35 (IL35)
  Organism Species: Homo sapiens (Human)
  Instruction manual
  FOR IN VITRO USE AND RESEARCH USE ONLY
  NOT FOR USE IN CLINICAL DIAGNOSTIC PROCEDURES
  11th Edition (Revised in May, 2016)
  [ PROPERTIES ]
  Source: Polyclonal antibody preparation
  Host: Rabbit
  Purification: Antigen-specific Affinity Chromatography. Traits: Liquid
  Concentration: 200μg/mL
  UOM: 50μg
  Applications: WB; ICC; IHC-P; IHC-F; ELISA; IP; IF; FCM. [ IMMUNOGEN ]
  Immunogen: RPC008Hu01-Recombinant Interleukin 35 (IL35)
  白介素35(IL35)多克隆抗體[ APPLICATIONS ]
  Western blotting: 0.5-2ug/ml
  Immunocytochemistry in formalin fixed cells: 5-20ug/ml
  Immunohistochemistry in formalin fixed frozen section: 5-20ug/ml
  Immunohistochemistry in paraffin section: 5-20ug/ml
  Enzyme-linked Immunosorbent Assay: 0.05-2ug/ml
  Optimal working dilutions must be determined by end user. [ FORMULATION ]
  Form & Buffer: Supplied as solution form in PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
  白介素35(IL35)多克隆抗體[ QUALITY CONTROL ]
  Content: The quality control contains recombinant IL35 disposed in loading
  buffer. Usage: 10uL per well when 3,3'-Diaminobenzidine(DAB) as the substrate. 5uL per well when used in enhanced chemilumescent (ECL). Note: The quality control is specifically manufactured as the positive control. Not used for other purposes. Loading Buffer: 100mM Tris(pH6.8), 1% SDS, 150mM NaCl, 50% glycerol, 0.02% BPB, 50mM DTT and 0.02% NaN3. [ STORAGE AND STABILITY ]
  Storage: Avoid repeated freeze/thaw cycles. Store at 4
  oC for frequent use. Aliquot and store at -20
  oC for 12 months. Stability Test: The thermal stability is described by the loss rate. The loss rate
  was determined by accelerated thermal degradation test, that is, incubate the
  protein at 37
  oC for 48h, and no obvious degradation and precipitation were
  observed.The loss rate is less than 5% within the expiration date under
  appropriate storage condition. [ IDENTIFICATION ]
  A
  Figure 1. Western Blot
  A. Sample: Recombinant IL35, Human
  A Figure 2. DAB staining on IHC-P Samples： A. Human Stomach Cancer Tissue B. Human Glioma Tissue C. Human Stomach Tissue D. Human Rectum Cancer Tissue C BD